Aldeyra Therapeu (NQ: ALDX )
5.570
+0.340
(+6.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Aldeyra Therapeu
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Aldeyra Therapeutics
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230503006049/en/1783451/22/Logo_400x399.jpg)
![](https://mms.businesswire.com/media/20230412005782/en/1762557/22/Logo_400x399.jpg)
![](https://mms.businesswire.com/media/20230405005610/en/1757160/22/Logo_400x399.jpg)
![](https://mms.businesswire.com/media/20230329005636/en/1751594/22/Logo_400x399.jpg)
![](https://mms.businesswire.com/media/20230314005733/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230308005858/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230301005873/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230228005935/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230227005902/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230222006066/en/1720980/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230213005640/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230208005570/en/836123/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20230206005693/en/1706787/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221220005785/en/1670483/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221212005860/en/1662974/22/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221130006151/en/1652066/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221128005848/en/1649011/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221109006044/en/1631955/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221102006089/en/1623559/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221024006055/en/1612568/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221005005917/en/1593829/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20221005005669/en/1593112/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20220913006271/en/1570896/5/ALDX_logo_JPEG.jpg)
![](https://mms.businesswire.com/media/20220906006042/en/1562861/5/ALDX_logo_JPEG.jpg)
Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
September 07, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.